Brigell D F, Fang V S, Rosenfield R L
Department of Medicine, University of Chicago, Pritzker School of Medicine, Illinois 60637-1470.
J Clin Endocrinol Metab. 1992 May;74(5):1036-9. doi: 10.1210/jcem.74.5.1314844.
To characterize the recovery of the hypothalamic-pituitary-adrenal axis from suppression by short-term glucocorticoid treatment, we examined the responses to ovine CRH (oCRH) before and after prednisolone administration. Eight normal male volunteers were studied before (control) and after administration of 25 mg prednisolone twice daily orally for 14 days. Data are mean +/- SEM. The ACTH basal level was suppressed 24 h after prednisolone withdrawal (1.7 +/- 0.4 pmol/L vs. control, 3.5 +/- 0.6, P less than 0.02), but the ACTH response to oCRH was not significantly different from control (peak 12.8 +/- 2.0 pmol/L vs. 13.5 +/- 12.1, respectively). Seventy-two h post prednisolone basal ACTH levels had recovered to pretreatment values. Cortisol levels, both basal and in response to oCRH, were significantly suppressed 24 h post prednisolone (P less than 0.001). By 72 h post prednisolone, both basal and oCRH-stimulated cortisol had recovered to pretreatment levels. Dehydroepiandrosterone (DHEA), both basal and stimulated, was significantly suppressed 24 h post prednisolone (P less than 0.001). In contrast to cortisol, basal and peak DHEA remained suppressed 72 h post prednisolone (basal DHEA 9.1 +/- 1.1 nmol/L, P less than 0.05 vs. control; peak DHEA 20.0 +/- 3.3 nmol/L, P less than 0.01 vs. control). When expressed as percent rise, however, the DHEA response to oCRH was not significantly different from control. DHEA sulfate (DHEAS) was significantly lower than control at both 24 and 72 h post prednisolone (1.8 +/- 0.3 and 3.3 +/- 0.4 mumol/L respectively; control 7.2 +/- 0.7 mumol/L; P less than 0.001). The ratio of basal DHEA to DHEAS was significantly higher than control 72 h post prednisolone, indicating that DHEAS was more profoundly suppressed than DHEA. We conclude that after a short course of prednisolone pituitary ACTH secretion is the first parameter of the hypothalamic-pituitary-adrenal axis to recover. Hypothalamic secretion of CRH recovers next, followed by recovery of cortisol secretion. Secretion of DHEA and DHEAS remain suppressed after recovery of cortisol. This suppression may be caused by inhibition of sulfokinase activity by glucocorticoid.
为了描述下丘脑 - 垂体 - 肾上腺轴从短期糖皮质激素治疗抑制状态下的恢复情况,我们检测了泼尼松龙给药前后对羊促肾上腺皮质激素释放激素(oCRH)的反应。对8名正常男性志愿者在(对照)用药前以及口服25 mg泼尼松龙每日2次共14天后进行了研究。数据为平均值±标准误。泼尼松龙撤药后24小时促肾上腺皮质激素(ACTH)基础水平受到抑制(1.7±0.4 pmol/L对比对照,3.5±0.6,P<0.02),但ACTH对oCRH的反应与对照无显著差异(峰值分别为12.8±2.0 pmol/L和13.5±12.1)。泼尼松龙撤药后72小时ACTH基础水平恢复到治疗前值。泼尼松龙撤药后24小时,皮质醇基础水平及对oCRH反应的水平均受到显著抑制(P<0.001)。到泼尼松龙撤药后72小时,基础及oCRH刺激的皮质醇均恢复到治疗前水平。脱氢表雄酮(DHEA)基础水平及刺激后水平在泼尼松龙撤药后24小时均受到显著抑制(P<0.001)。与皮质醇不同,泼尼松龙撤药后72小时DHEA基础水平及峰值仍受到抑制(基础DHEA 9.1±1.1 nmol/L,与对照相比P<0.05;峰值DHEA 20.0±3.3 nmol/L,与对照相比P<0.01)。然而,以升高百分比表示时,DHEA对oCRH的反应与对照无显著差异。硫酸脱氢表雄酮(DHEAS)在泼尼松龙撤药后24小时和72小时均显著低于对照(分别为1.8±0.3和3.3±0.4 μmol/L;对照为7.2±0.7 μmol/L;P<0.001)。泼尼松龙撤药后72小时基础DHEA与DHEAS的比值显著高于对照,表明DHEAS比DHEA受到更显著的抑制。我们得出结论,短期泼尼松龙治疗后,垂体ACTH分泌是下丘脑 - 垂体 - 肾上腺轴恢复的首个参数。接下来是促肾上腺皮质激素释放激素(CRH)的下丘脑分泌恢复,随后是皮质醇分泌恢复。皮质醇恢复后,DHEA和DHEAS的分泌仍受到抑制。这种抑制可能是由糖皮质激素对磺激酶活性的抑制引起的。